Volker Auwärter

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Jeremy Carlier

Marche Polytechnic University

ITALY

View details

Guido Pelletti

University of Bologna

ITALY

View details

Wolfgang Weinmann

University of Bern

SWITZERLAND

View details

Maren Hermanns-Clausen

University Medical Center Freiburg

GERMANY

View details

Simon D. Brandt

UNITED KINGDOM

View details

Adam L. Halberstadt

UNITED STATES

View details

Henrik Gréen

Professor

Linköping University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Volker Auwärter

Research Interests

Explore related searches

Contact this professor

Articles (20)

Interpreting mono- and poly-SCRA intoxications from an activity-based point of view: JWH-018 equivalents in serum as a comparative measure

Exploring the Metabolism of Flubrotizolam, a Potent Thieno-Triazolo Diazepine, Using Human Hepatocytes and High-Resolution Mass Spectrometry

Human phase‐I metabolism of three synthetic cannabinoids bearing a cumyl moiety and a cyclobutyl methyl or norbornyl methyl tail: Cumyl‐CBMEGACLONE, Cumyl‐NBMEGACLONE, and Cumyl‐NBMINACA

Missbrauch neuer synthetischer Cannabinoide im Maßregelvollzug

Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene

Insights into the metabolism of CH-PIATA—A novel synthetic cannabinoid featuring an acetamide linker

Enzymatic Defluorination of a Terminally Monofluorinated Pentyl Moiety: Oxidative or Hydrolytic Mechanism?

Synthetic cannabinoids in hair—Prevalence of use in abstinence control programs for driver's license regranting in Germany

ADB‐HEXINACA—a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market

Identification of human hexahydrocannabinol metabolites in urine

Pharmacological profile, phase I metabolism, and excretion time profile of the new synthetic cathinone 3,4‐Pr‐PipVP

Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration study

Analytical and behavioral characterization of <i>N</i>‐ethyl‐<i>N</i>‐isopropyllysergamide (EIPLA), an isomer of <i>N</i><sup>6</sup>–ethylnorlysergic acid <i>N</i>,<i>N</i>‐diethylamide (ETH‐LAD)

Analytical profile of the lysergamide 1cP‐AL‐LAD and detection of impurities

Human metabolism and basic pharmacokinetic evaluation of AP‐238: A recently emerged acylpiperazine opioid

Human phase‐I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F‐EDMB‐PICA and EDMB‐PINACA

A new synthetic cathinone: 3,4‐EtPV or 3,4‐Pr‐PipVP? An unsuccessful attempt to circumvent the German legislation on new psychoactive substances

Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids

Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P‐AL‐LAD

Detection of AP‐237 and synthetic cannabinoids on an infused letter sent to a German prisoner

Collaborators (7)

Jeremy Carlier

Guido Pelletti

Wolfgang Weinmann

Maren Hermanns-Clausen

Simon D. Brandt

Adam L. Halberstadt

Henrik Gréen

Make your next move.